News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Glioblastoma Treatment
September 24, 2025
Vorangio (vorasidenib)-IDH Targeted Therapy for Low-Grade Glioma
Charles H. Weaver, MD
August 28, 2025
Strategies to Improve Treatment of Glioblastoma & Advanced Brain Cancers
Charles H. Weaver, MD
August 20, 2025
FDA Grants Accelerated Approval to Dordaviprone (Modeyso) for Diffuse Midline Glioma with H3 K27M Mutation
Charles H. Weaver, MD
July 25, 2025
SurvaxM May Prolong Survival in Glioblastoma
Charles H. Weaver, MD
August 7, 2024
CAR T Cell Therapy for Treatment of Solid Tumors
Charles H. Weaver, MD
January 17, 2023
Tovorafenib in Pediatric Low-Grade Glioma
Charles H. Weaver, MD
November 1, 2022
Brachytherapy and Glioblastoma
Charles H. Weaver, MD
November 30, 2021
Breakthrough: Precision Medicines for Glioblastoma?
Charles H. Weaver, MD
October 17, 2020
Neulasta Treatment of Neutropenia Improves Treatment
Charles H. Weaver, MD
June 8, 2019
Certain Patients With Glioblastoma Appear to Respond to Selinexor
Charles H. Weaver, MD
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
